After a 2005 diagnosis of osteoporosis, Field launched the public-facing 'Rally with Sally for Bone Health' campaign to raise awareness of bone-density screening and early diagnosis. The effort was funded with the support of pharmaceutical companies Roche and GlaxoSmithKline and controversially co-promoted the bisphosphonate drug Boniva. Critics and some public-health observers argued the campaign blurred the line between public education and pharmaceutical marketing, turning a celebrity health initiative into a de facto ad for a specific treatment. Field defended the public-health intent — urging testing and prevention — but the episode remains a textbook example of how celebrity advocacy can become entangled with industry interests and attract backlash even when grounded in a genuine medical diagnosis.
Preparing the daily feature…
AI concept artworkArchive Record · 2000s
Rally With Sally: Field's osteoporosis campaign and the controversy over pharma tie‑ins
Sally Field / Rally With Sally campaign / 2000s
After a 2005 diagnosis of osteoporosis, Field launched the public-facing 'Rally with Sally for Bone Health' campaign to raise awareness of bone-density screening and early diagnosis. The effort was funded with the support of pharmaceutical companies Roche and GlaxoSmithKline and controversially co-promoted the bisphosphonate drug Boniva. Critics and some public-health observers argued the campaign blurred the line between public education and pharmaceutical marketing, turning a celebrity health initiative into a de facto ad for a specific treatment. Field defended the public-health intent — urging testing and prevention — but the episode remains a textbook example of how celebrity advocacy can become entangled with industry interests and attract backlash even when grounded in a genuine medical diagnosis.
The daily feature is taking an intermission. There’s still an entire archive to explore.